Juliann Dziubinski

发表论文 15 篇 · 总被引 141 次 · h-index 5

代表论文

• Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung Cancer (2016 · Clinical Cancer Research · 被引 82)
• Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer (2017 · Journal of Thoracic Oncology · 被引 22)
• A phase III study of rovalpituzumab tesirine maintenance therapy following first-line platinum-based chemotherapy in patients with extensive disease small cell lung cancer (ED SCLC). (2017 · Journal of Clinical Oncology · 被引 13)
• P1.04-006 Rovalpituzumab Tesirine vs Topotecan in Patients with Advanced Small Cell Lung Cancer Following 1st Line Chemotherapy (2017 · Journal of Thoracic Oncology · 被引 9)
• A Randomized, Double-Blind, Phase 2 Trial of Veliparib (Abt-888) with Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer (2014 · Annals of Oncology · 被引 7)
• A phase 3 trial of rovalpituzumab tesirine vs topotecan in patients with advanced small cell lung cancer following frontline platinum-based chemotherapy (2017 · Annals of Oncology · 被引 4)